Related Experiment Video
Updated: Jan 22, 2026

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung
Jinwu Peng1,2,3, Yuting Zhan4, Juan Feng4
1Department of Pathology, Xiangya Basic Medical School, Central South University, Changsha 410013, Hunan, China.
Abstract:
Non-small cell lung cancer (NSCLC) represents a major health burden globally. WD repeat protein 79 (WDR79) is a member of the WD-repeat protein family. WDR79 is a highly conserved and natural antisense transcript to TP53 gene and involved in carcinogenesis of various types of cancer. Whether the alterations of WDR79 protein expression are associated with TP53 mutation and clinicopathological and prognostic implications in the patients with surgically resected NSCLC have not been reported. The purposes of the present study are to investigate the association between the expression of WDR79 and mutant p53 (mtp53) and clinicopathological features in NSCLC by immunohistochemistry. The results showed that positive expression of WDR79 (58.8%, 170/289) and mtp53 (48.1%, 139/289) in NSCLC was significantly higher than that in non-cancerous control lung tissues (5.7%, 3/53 and 1.9%, 1/53, respectively). There was a significantly higher positive percentage of WDR79 expression in NSCLC with lymph node metastasis. The statistically positive correlation between WDR79 and mtp53 expression (r = 0.212, P=0.014) was identified by Spearman's rank correlation analysis. Kaplan-Meier survival curve analysis indicated that positive expression of WDR79 and common positive expression of WDR79 and mtp53 were correlated with poor overall survival rates in NSCLC patients (P = 0.029 and P = 0.041, respectively). Multivariate Cox regression analysis further identified that WDR79 positive expression was an independent unfavorable prognostic factor of NSCLC (P = 0.034). Taken together, positive expression of WDR79 proteins may be related with TP53 mutations and act as valuable independent biomarker to predict poor prognosis of patients with surgically resected NSCLC.
Insights
WD repeat protein 79 (WDR79) expression is elevated in non-small cell lung cancer (NSCLC) and linked to TP53 mutations. High WDR79 levels indicate poor prognosis and serve as a potential biomarker for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) poses a significant global health challenge.
- WD repeat protein 79 (WDR79), a conserved natural antisense transcript to the TP53 gene, is implicated in various cancers.
- The association between WDR79 expression, TP53 mutations, and clinical outcomes in NSCLC remains uninvestigated.
Purpose of the Study:
- To investigate the relationship between WDR79 protein expression and mutant p53 (mtp53) in NSCLC.
- To analyze the correlation between WDR79 expression and clinicopathological features in NSCLC patients.
- To determine the prognostic significance of WDR79 expression in surgically resected NSCLC.
Main Methods:
- Immunohistochemistry was employed to assess WDR79 and mtp53 expression in NSCLC tissues and non-cancerous lung tissues.
- Spearman's rank correlation analysis was used to evaluate the association between WDR79 and mtp53 expression.
- Kaplan-Meier survival analysis and multivariate Cox regression were performed to assess prognostic implications.
Main Results:
- Positive WDR79 (58.8%) and mtp53 (48.1%) expression were significantly higher in NSCLC compared to controls.
- WDR79 expression was significantly associated with lymph node metastasis.
- A positive correlation was found between WDR79 and mtp53 expression (r=0.212, P=0.014).
Conclusions:
- Positive WDR79 expression is linked to TP53 mutations in NSCLC.
- WDR79 expression, alone or with mtp53, correlates with poorer overall survival in NSCLC patients.
- WDR79 serves as an independent prognostic biomarker for predicting poor outcomes in surgically resected NSCLC.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Cell Specific Gene Expression

